Shannon Matheny
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Radiopharmaceutical Chemistry and Applications, Colorectal Cancer Treatments and Studies, HER2/EGFR in Cancer Research
Most-Cited Works
- → Hypoxia and the hypoxia-inducible-factor pathway in glioma growth andangiogenesis(2005)682 cited
- → Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer(2015)660 cited
- → A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma(2016)284 cited
- → Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)(2016)179 cited
- → Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results(2015)134 cited
- → BAI1 regulates spatial learning and synaptic plasticity in the hippocampus(2015)90 cited
- → VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms(2005)82 cited
- → Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001(2018)52 cited
- → Epidermal growth factor receptor (EGFR) genotyping of matched urine, plasma and tumor tissue from non-small cell lung cancer (NSCLC) patients (pts) treated with rociletinib.(2016)32 cited
- → Vascular endothelial growth factor‐D is a survival factor for human breast carcinoma cells(2005)25 cited